Back to BlackRock, Inc. BlackRock, Inc.

AMPHAMPH
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in AMPHASTAR PHARMACEUTICALS IN

BlackRock, Inc. holds 5.2M shares of AMPH (AMPHASTAR PHARMACEUTICALS IN), worth $105.4M as of 2026-Q2. The position was decreased (-3.6% shares). AMPH represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$105.4M

Current Shares

5.2M

Total Value Change

-$121.7M

Total Shares Change

-892,888

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.2M
-3.6%
$105.4M0.0%$20.18
0
2026-Q1
Decreased
5.4M
-0.7%
$106.2M0.0%$19.83
0
2025-Q4
Decreased
5.5M
-0.4%
$146.3M0.0%$27.00
0
2025-Q3
Decreased
5.5M
-3.2%
$146.2M0.0%$26.92
0
2025-Q2
Decreased
5.7M
-7.8%
$130.2M0.0%$23.08
0
2025-Q1
Increased
6.1M
+0.5%
$178.2M0.0%$28.43
30
2024-Q4
New
6.1M
-
$227.2M0.0%$36.84
42

Other major holders of AMPH: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used